血清VEGF-A及其受體VEGFR-2水平與鼻咽癌患者淋巴結(jié)轉(zhuǎn)移的關(guān)系
[Abstract]:Objective: to investigate the level of serum VEGF-A/VEGFR-2 in patients with nasopharyngeal carcinoma (NPC) and its relationship with clinicopathological parameters and lymph node metastasis. Methods: enzyme linked immunosorbent assay (ELISA) was used to detect 32 patients with nasopharyngeal carcinoma (NPC), 9 patients with recurrent nasopharyngeal carcinoma (NPC) and 21 patients with complete remission after nasopharyngeal carcinoma (NPC) treatment. The levels of VEGF-A and VEGFR-2 in the serum of 6 patients with distant metastasis of nasopharyngeal carcinoma were compared with those of 20 healthy controls. The levels of VEGF-A/VEGFR-2 were compared with the clinicopathological features of each group. Relationship between TNM staging and lymph node metastasis. Results: the serum VEGF-A,VEGFR-2 levels in nasopharyngeal carcinoma patients were significantly higher than those in healthy controls (P0.01). The serum VEGF-A,VEGFR-2 level in recurrent nasopharyngeal carcinoma patients was significantly higher than that in complete remission group (P0.01). Serum VEGF-A and VEGFR-2 levels were correlated with T stage and N stage of nasopharyngeal carcinoma (P0.01). The serum levels of VEGF-A and VEGFR-2 in patients with lymph node metastasis were significantly higher than those in patients without lymph node metastasis, and the two molecules were positively correlated with lymphatic metastasis of nasopharyngeal carcinoma. The serum levels of VEGF-A and VEGFR-2 in patients with recurrent nasopharyngeal carcinoma were significantly higher than those in healthy controls (P0.01, P0.01). The levels of VEGF-A and VEGFR-2 in the complete remission group were not significantly different from those in the healthy control group (P0.05), and the levels of VEGF-A and VEGFR-2 in the serum of the patients were correlated with those of the healthy control group (P 0.05). Conclusion: the occurrence and progression of nasopharyngeal carcinoma are related to the levels of serum VEGF-A and VEGFR-2 in patients with nasopharyngeal carcinoma. The contents of VEGF-A and VEGFR-2 in serum of patients with nasopharyngeal carcinoma are related to the clinicopathological TNM stage and lymphatic metastasis. VEGF-A/VEGFR-2 level can be used as a predictor of lymphatic metastasis.
【學(xué)位授予單位】:桂林醫(yī)學(xué)院
【學(xué)位級別】:碩士
【學(xué)位授予年份】:2012
【分類號】:R739.63
【相似文獻】
相關(guān)期刊論文 前10條
1 趙永忠;血管內(nèi)皮生長因子與消化系腫瘤關(guān)系的研究進展[J];國外醫(yī)學(xué).內(nèi)科學(xué)分冊;2002年01期
2 譚先杰,劉東遠;血管內(nèi)皮生長因子研究進展與子宮內(nèi)膜異位癥[J];國外醫(yī)學(xué).婦產(chǎn)科學(xué)分冊;2000年05期
3 王水,武正炎,范萍,查小明;血管內(nèi)皮細(xì)胞生長因子在乳腺癌組織中的表達及其生物學(xué)意義[J];南京醫(yī)科大學(xué)學(xué)報(自然科學(xué)版);2001年06期
4 畢蕙,李克敏;子宮腫瘤與血管生成[J];中國婦產(chǎn)科臨床雜志;2001年05期
5 高勇,王杰軍;腫瘤血管生長和缺氧誘導(dǎo)因子[J];國外醫(yī)學(xué).腫瘤學(xué)分冊;2001年01期
6 李驍雄;中樞神經(jīng)系統(tǒng)血管畸形性疾病中VEGF的表達[J];神經(jīng)疾病與精神衛(wèi)生;2001年04期
7 徐力,李艷,鄒雄,馬萬山;乳腺癌患者血清VEGF含量測定及臨床意義[J];山東醫(yī)藥;2002年02期
8 邱曉紅,張卉,張繼紅;VEGF及MVD在子宮內(nèi)膜癌中的表達[J];中國老年學(xué)雜志;2002年03期
9 韋方,耿慶山,張斌,馮建章,余細(xì)勇,蔣祖勛,周鋼;轉(zhuǎn)VEGF基因?qū)ρ軗p傷后平滑肌細(xì)胞增殖和表型的影響[J];嶺南心血管病雜志;2002年05期
10 車向明,許延發(fā),王康,盛薇,賈建洛;早期胃癌血管內(nèi)皮生長因子的表達及其與淋巴結(jié)轉(zhuǎn)移的關(guān)系[J];中華胃腸外科雜志;2002年04期
相關(guān)會議論文 前10條
1 趙忠芳;呂仁榮;霍然;傅洪濱;徐廣琪;;普萘洛爾治療增生期血管瘤患兒血清中VEGF、MMP-9的變化[A];中華醫(yī)學(xué)會整形外科學(xué)分會第十一次全國會議、中國人民解放軍整形外科學(xué)專業(yè)委員會學(xué)術(shù)交流會、中國中西醫(yī)結(jié)合學(xué)會醫(yī)學(xué)美容專業(yè)委員會全國會議論文集[C];2011年
2 徐勇;黃仁魏;王東寧;林桂真;林東軍;何易;李旭東;林曲;;急性白血病血管內(nèi)皮生長因子(VEGF)和受體的表達及其臨床意義研究[A];中華醫(yī)學(xué)會第八次全國血液學(xué)學(xué)術(shù)會議論文匯編[C];2004年
3 李飛;李樹清;;VEGF表達在局灶性腦缺血后亞低溫腦保護中的作用研究[A];中國病理生理學(xué)會第九屆全國代表大會及學(xué)術(shù)會議論文摘要[C];2010年
4 趙忠芳;呂仁榮;霍然;傅洪濱;徐廣琪;;普萘洛爾治療增生期血管瘤患兒血清中VEGF、MMP-9的變化[A];中華醫(yī)學(xué)會整形外科學(xué)分會第十一次全國會議、中國人民解放軍整形外科學(xué)專業(yè)委員會學(xué)術(shù)交流會、中國中西醫(yī)結(jié)合學(xué)會醫(yī)學(xué)美容專業(yè)委員會全國會議論文集[C];2011年
5 杜娟;王景美;錢曉萍;劉寶瑞;;COX-2和VEGF在胃癌中的表達和意義[A];中華醫(yī)學(xué)會腫瘤學(xué)分會第七屆全國中青年腫瘤學(xué)術(shù)會議——中華醫(yī)學(xué)會腫瘤學(xué)分會“中華腫瘤 明日之星”大型評選活動暨中青年委員全國遴選論文匯編[C];2011年
6 田,
本文編號:2319898
本文鏈接:http://sikaile.net/yixuelunwen/wuguanyixuelunwen/2319898.html